Passaia, B. d. S., Dias, M. H., Kremer, J. L., Antonini, S. R. R., de Almeida, M. Q., Fragoso, M. C. B. V., & Lotfi, C. F. P. (2018). TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors. Front Endocrinol (Lausanne).
Citação norma ChicagoPassaia, Barbara dos Santos, Matheus Henrique Dias, Jean Lucas Kremer, Sonir Roberto Rauber Antonini, Madson Queiroz de Almeida, Maria Candida Barisson Villares Fragoso, and Claudimara Ferini Pacicco Lotfi. "TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, As a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors." Front Endocrinol (Lausanne) 2018.
MLA citiranjePassaia, Barbara dos Santos, et al. "TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, As a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors." Front Endocrinol (Lausanne) 2018.